IL6 and neoplasm: The results showed that XQ‐2d‐His‐SH2 CM‐(Arg)9 could decrease the concentrations of IL6 and LIF in PDAC mouse model in the tumor tissues and blood, whereas IL‐11 exhibited no obvious change (Figure 8F and G).